ArticleThe oncologist2026

An assessment of time toxicity in patients receiving [177Lu]Lu-PSMA-617 for metastatic castration-resistant prostate cancer.

Zachary Scharf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.